| Announce Date | 10/28/2025 |
| EPS Normalized Actual | $0.32 (Beat by $0.1) |
| EPS GAAP Actual | $0.32 (Beat by $0.1) |
| Revenue Actual | $0.395163B |
| Revenue Surprise | Beat by $395.163M |
| Announce Date | 12/31/1969 (Pre-Market) |
| EPS Normalized Estimate | $ |
| EPS GAAP Estimate | $ |
| Revenue Estimate | $0B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2029 | 1.0008 | 18.58 | 0.96453 | 1.04091 | 3 |
| Dec 2028 | 0.3185 | 58.37 | 0.29121 | 0.34208 | 2 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 1.42 | 1.42 | 0.395163B | 20.69% | 395.16M |
| FQ2 2025 (Jun 2025) | 0.33 | 0.33 | 0.288343B | 4.57% | 288.34M |
| FQ1 2025 (Mar 2025) | 0.15 | 0.15 | 0.299499B | -1.3% | 299.5M |
| FQ4 2024 (Dec 2024) | -0.26 | -0.26 | 0.302387B | -14.21% | 302.39M |
| FQ3 2024 (Sep 2024) | 0.14 | 0.14 | 0.313422B | -9.72% | 313.42M |
| FQ2 2024 (Jun 2024) | 0.18 | 0.18 | 0.275166B | 32.94% | 275.17M |
| FQ1 2024 (Mar 2024) | 0.31 | 0.31 | 0.303398B | 25.34% | 303.4M |
| FQ4 2023 (Dec 2023) | -0.14 | -0.14 | 0.345355B | 100% | 345.36M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 0.30768 | -- | 0.30768 | 0.30768 | 1 |
| FQ3 2027 (Sep 2027) | 0.2644 | -- | 0.2644 | 0.2644 | 1 |
| FQ2 2027 (Jun 2027) | 0.2873 | -- | 0.2873 | 0.2873 | 1 |
| FQ1 2027 (Mar 2027) | 0.4175 | -- | 0.4175 | 0.4175 | 1 |
| FQ4 2026 (Oct 2026) | 0.04765 | -- | 0.04765 | 0.04765 | 0 |
| FQ3 2026 (Jul 2026) | 0.06215 | -2184.79 | 0.06215 | 0.06215 | 0 |
| FQ2 2026 (Jun 2026) | 0.31365 | -5.21 | 0.31365 | 0.31365 | 1 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 0.56B | -- | 0.56B | 0.56B | 1 |
| FQ3 2027 (Sep 2027) | 0.6B | -- | 0.6B | 0.6B | 1 |
| FQ2 2027 (Jun 2027) | 0.51B | -- | 0.51B | 0.51B | 1 |
| FQ1 2027 (Mar 2027) | 0.55B | -- | 0.55B | 0.55B | 1 |
| FQ4 2026 (Oct 2026) | 0.22B | -- | 0.22B | 0.22B | 0 |
| FQ3 2026 (Jul 2026) | 0.22B | -79.21 | 0.22B | 0.22B | 0 |
| FQ2 2026 (Jun 2026) | 0.41B | 29.65 | 0.41B | 0.41B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
6
EPS # of Misses
2
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 1.42 | 1.42 | 100% | |
| FQ2 2025 (Jun 2025) | 0.33 | 0.33 | 100% | |
| FQ1 2025 (Mar 2025) | 0.15 | 0.15 | 100% | |
| FQ4 2024 (Dec 2024) | -0.26 | -0.26 | 100% | |
| FQ3 2024 (Sep 2024) | 0.14 | 0.14 | 100% | |
| FQ2 2024 (Jun 2024) | 0.18 | 0.18 | 100% | |
| FQ1 2024 (Mar 2024) | 0.31 | 0.31 | 100% | |
| FQ4 2023 (Dec 2023) | -0.14 | -0.14 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $0B | $0.4B | $395.16M | 100% |
| FQ2 2025 (Jun 2025) | $0B | $0.29B | $288.34M | 100% |
| FQ1 2025 (Mar 2025) | $0B | $0.3B | $299.5M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $0.3B | $302.39M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $0.31B | $313.42M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $0.28B | $275.17M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $0.3B | $303.4M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $0.35B | $345.36M | 100% |